Will Morton[email protected]Molecular ImagingFAPI-SPECT reveals damage to myocardium after heart attackTechnetium-99m (Tc-99m) FAPI-SPECT shows promise as a tool for assessing cellular and structural changes in the myocardium after heart attack.July 16, 2024Nuclear MedicineBone marrow disorders associated with SARs in Lutathera patientsPretreatment bone marrow disorders may predict which patients are at risk for severe adverse reactions (SARs) when treated with lutetium-177 DOTATATE.July 15, 2024Radiation Oncology/TherapyRisk factor for blood disorders identified in PRRT patientsResearchers have identified a risk factor that may be involved in potentially fatal blood disorders in patients undergoing peptide receptor radionuclide therapy (PRRT).July 12, 2024Molecular ImagingNew CMS plan adds Medicare coverage of PET imaging agentsThe CMS proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m.July 10, 2024Digital X-RayAI improves evaluations of knee osteoarthritis on x-raysA commercially available AI algorithm improved the performance of junior radiologists when grading knee osteoarthritis on x-rays.July 9, 2024Molecular ImagingLAFOV PET/CT feasible in infants with neuroblastomaLong axial field-of-view (LAFOV) PET/CT scanners offer shorter procedure times and avoid the need for sedation or general anesthesia when imaging young children with neuroblastoma.July 9, 2024Molecular ImagingSwiss team produces 1st 3D PET/MRI imageResearchers at the University of Zurich in Switzerland say they have produced the first cinematically rendered image from a patient based on a standard clinical F-18 FDG-PET/MRI scan.July 5, 2024Molecular ImagingShine CEO: Chrysalis to be world’s largest medical isotope producerGreg Piefer, PhD, founder and CEO of Shine Technologies, says the company is two years away from launching world’s largest medical isotope facility.July 3, 2024Molecular ImagingFDG-PET/CT improves management of patients with head and neck cancerFDG-PET/CT imaging can reduce unnecessary surgeries in patients to remove residual neck cancer after they have undergone chemoradiotherapy.July 2, 2024Molecular ImagingPSMA-PET superior to MRI in phase II prostate cancer trialPET/CT imaging with a new radiotracer is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer.July 1, 2024Previous PagePage 23 of 51Next PageTop StoriesDigital X-RayAI predicts death risk from COPDAn AI model for analyzing chest x-rays can identify individuals at risk of death from chronic obstructive pulmonary disease (COPD)Womens ImagingMusic lowers anxiety, pain for women undergoing mammographyMRI5 ways to reduce gadolinium pollutionMinniesMeet the Minnies 2025 finalistsSponsor ContentClinically Meaningful AI Detection of Interval Cancers
